Ind-Swift Share Price
Small Cap | Pharmaceuticals and health care | NSE: INDSWFTLTD | BSE: 524652
₹14.91 0.06 (0.40 %)
Last Updated: 25 Feb 2025 12:00 AM
Overview
Open (₹) 15.15
High (₹) 15.27
Low (₹) 14.91
Prev. Close (₹) 14.85
Volume 321
VWAP (₹) 15.22
ROCE (%) 23.76
Industry P/E 43.77
TTM P/E 1.25
P/B Ratio -0.12
Market Cap (₹) Cr.81.19
Dividend Yield (%)--
EPS (₹) 2.63
ROE-2.06%
Sales Growth (%) 22.21
Profit Growth (%)-45.34
Day Range
15.2715.27
52 Week Range
13.2534.49
Historical Returns
Returns (6M)
-38.39 %
Returns (1Y)
-20.94 %
Returns (3Y)
40.4 %
Returns (5Y)
452.22 %
Returns (6M)
-38.39 %
Returns (1Y)
-20.94 %
Returns (3Y)
40.4 %
Returns (5Y)
452.22 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with Low Debt
- Book value per share improving over the last 2 years
- Increasing Annual Revenue for Past 2 Years
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 41.92
MFI 21.93
ATR 0.93
Commodity Channel Index -33.15
ROC125 -38.84
ROC21 -25.97
Williams %R -60.00
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 15.15 | 15.39 | 15.51 | 15.03 | 14.79 | 14.67 | 14.43 |
Week Ago | 14.35 | 14.74 | 15.29 | 13.80 | 13.41 | 12.86 | 12.47 |
Month Ago | 22.78 | 23.24 | 23.48 | 22.54 | 22.08 | 21.84 | 21.38 |
EMA & SMA
14.91
Current Price
Bullish Moving Averages
10
Bearish Moving Averages
10
5 Day 14.45
9 Day 14.52
10 Day 14.35
12 Day 14.71
14 Day 14.86
20 Day 15.93
26 Day 17.66
50 Day 22.51
100 Day 22.37
200 Day 22.43
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
ALTRUISTIC TRADING PRIVATE LIMITED | bulk | Sell | 09 Aug, 2021 | ₹10.10 | 2,95,000 | BSE |
Insider Trading
Corporate Actions
No corporate actions available.
Announcements
Date | Source | Detail |
---|---|---|
25 Feb, 2025 | NSE India | Ind-Swift Limited has informed the Exchange about the scrutinizer report along with voting results w.r.t NCLT Convened meeting of Unsecured creditors of the Company |
25 Feb, 2025 | BSE India | Please find enclosed scrutinizer''s report along with voting results w.r.t NCLT Convened meeting of Unsecured creditors of the Company |
25 Feb, 2025 | NSE India | Ind-Swift Limited has submitted the Exchange a copy of Srutinizers report of NCLT Convened General Meeting held on February 22, 2025. Further, the company has informed the Exchange regarding voting results. |
25 Feb, 2025 | BSE India | Please find enclosed scrutinizer''s report along with voting results w.r.t NCLT Convened meeting of Equity shareholders of the Company |
22 Feb, 2025 | NSE India | Ind-Swift Limited has informed the Exchange regarding Proceedings of NCLT Convened Meeting of the Unsecured Creditors held on February 22, 2025 |
22 Feb, 2025 | BSE India | The proceedings of NCLT Convened meeting of Unsecured creditors of Ind Swift Limited is enclosed herewith |
22 Feb, 2025 | NSE India | Ind-Swift Limited has informed the Exchange regarding Proceedings of NCLT Convened General Meeting held on February 22, 2025 |
22 Feb, 2025 | BSE India | The proceedings of NCLT Convened meeting of the Equity shareholders of Ind Swift Limited is enclosed herewith. |
20 Feb, 2025 | NSE India | IND-SWIFT LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
20 Feb, 2025 | NSE India | Ind-Swift Limited has informed the Exchange regarding Appointment of Mr. Anil Agrawal as Other of the company w.e.f. February 20, 2025. |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 07 Feb, 2025 | 11 Feb, 2025 |
Quarterly Results | -- | 09 Nov, 2024 | 14 Nov, 2024 |
Quarterly Results | -- | 02 Aug, 2024 | 13 Aug, 2024 |
Audited Results | -- | 07 May, 2024 | 14 May, 2024 |
Quarterly Results | (Revised) | 08 Feb, 2024 | 14 Feb, 2024 |
Quarterly Results | -- | 08 Feb, 2024 | 13 Feb, 2024 |
Quarterly Results | -- | 31 Oct, 2023 | 09 Nov, 2023 |
Quarterly Results | -- | 02 Aug, 2023 | 10 Aug, 2023 |
Audited Results | -- | 17 May, 2023 | 30 May, 2023 |
Quarterly Results | -- | 31 Jan, 2023 | 13 Feb, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
---|
About Ind-Swift
Ind-Swift is a Public Limited Listed company incorporated on 06/06/1986 and has its registered office in the State of Chandigarh, India. Company’s Corporate Identification Number(CIN) is L24230CH1986PLC006897 and registration number is 006897. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 502.25 Cr. and Equity Capital is Rs. 10.83 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1986
Managing Director
Dr. Gopal Munjal
NSE Symbol
INDSWFTLTD
Ind-Swift Management
Name | Designation |
---|---|
Mr. S R Mehta | Executive Chairman |
Mr. N R Munjal | Non Executive Director |
Dr. Gopal Munjal | Managing Director & CEO |
Dr. V R Mehta | Joint Managing Director |
Mr. Himanshu Jain | Non Executive Director |
Mr. Rishav Mehta | Non Executive Director |
Mr. S P Sharma | Independent Director |
Dr. V K Arora | Independent Director |
Mr. S C Galhotra | Independent Director |
Ms. Anoop Michra | Independent Director |
Mr. Jagvir Singh Ahluwalia | Independent Director |
Mr. Bhupinder Singh | Independent Director |
Mr. Subodh Gupta | Independent Director |
Mr. Prabhat Khurana | Independent Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
SunPhrmInds | ₹4,46,576.22 | ₹1,613.60 ₹1,639.50(-1.58%) | ₹1,249.800 - ₹1,960.200 |
Divis Labora | ₹1,56,123.40 | ₹5,726.40 ₹5,702.55(0.42%) | ₹3,350.050 - ₹6,448.750 |
Cipla | ₹1,21,675.13 | ₹1,463.35 ₹1,476.75(-0.91%) | ₹1,240.700 - ₹1,702.000 |
ManKind Phar | ₹1,18,478.90 | ₹2,342.10 ₹2,298.80(1.88%) | ₹1,910.100 - ₹3,050.000 |
DrReddysLab | ₹1,15,939.04 | ₹1,128.15 ₹1,164.55(-3.13%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Ind-Swift
What is the share price of Ind-Swift?
The share price of Ind-Swift on 25 Feb, 2025 is ₹ 14.91.
What is 52W high and 52W low share price of Ind-Swift?
The highest and lowest 52W share prices of Ind-Swift are ₹ 32.490 and ₹ 15.190
What is the market cap of Ind-Swift?
The market capitalization of Ind-Swift as of 25 Feb, 2025 is ₹ 81.19 Crores
What is the P/E ratio of Ind-Swift?
The current P/E ratio of Ind-Swift as of 25 Feb, 2025 is 43.77
What is the PB ratio of Ind-Swift?
The PB ratio of Ind-Swift as of 25 Feb, 2025 is -0.12
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)